Cover Image

Bismuth, An Indispensable Component of Helicobacter pylori Eradication Therapy

Saved in:

Bibliographic Details
Main Author:	Kyung Ho Song (Author)
Format:	Book
Published:	Yong Chan Lee, 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bismuth-containing Standard Triple Therapy the First-line Eradication Therapy for Helicobacter pylori
by: Yeon-Ji Kim, et al.
Published: (2021)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
by: Min Niu, et al.
Published: (2022)

The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020)

Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
by: Arash Kazemi, et al.
Published: (2023)

Empiric "Three-in-One" Bismuth Quadruple Therapy for Second-Line <em>Helicobacter pylori</em> Eradication: An Intervention Study in Southern Italy
by: Giuseppe Losurdo, et al.
Published: (2022)

A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
by: Sung Eun Kim, et al.
Published: (2021)

Concomitant and Bismuth Quadruple Therapy for <i>Helicobacter pylori</i> Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial
by: Giuseppe Losurdo, et al.
Published: (2024)

Antibiotic Resistance and Helicobacter pylori Eradication Therapy
by: Younghee Choe
Published: (2023)

Eradication Therapy for Pediatric Helicobacter pylori Infection
by: Ji-Hyun Seo, et al.
Published: (2017)

Helicobacter pylori Eradication Therapy-associated Diarrhea
by: Hoon Gil Jo, et al.
Published: (2021)

Efficacy of Ecabet Sodium for Helicobacter pylori Eradication with Sequential Therapy
by: Seol So, et al.
Published: (2018)

Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for <i>Helicobacter pylori</i> Eradication in High Clarithromycin Resistance Areas
by: Sotirios D. Georgopoulos, et al.
Published: (2024)

Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
by: Antonietta G. Gravina, et al.
Published: (2021)

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
by: Mitsushige Sugimoto, et al.
Published: (2019)

Effect of Diabetes Mellitus on Helicobacter pylori Eradication Therapy
by: Sung Eun Kim
Published: (2017)

Helicobacter pylori Eradication Rate in Patients with Diabetes
by: Jiyeon Yoo, et al.
Published: (2017)

In Vitro Susceptibility and Synergistic Effect of Bismuth Against <i>Helicobacter pylori</i>
by: Jieun Woo, et al.
Published: (2024)

Can Gastric Helicobacter Pylori Eradication Increase by Eradication of Oral Helicobacter Pylori by Periodontal Treatment? Literature Review
by: Ayla ÖZTÜRK
Published: (2023)

Status of Helicobacter pylori Eradication in Japan
by: Gwang Ha Kim
Published: (2017)

Helicobacter pylori Eradication in the Management of Glaucoma
by: Shahram Ala, et al.
Published: (2020)

Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
by: Seung In Seo, et al.
Published: (2022)

Vonoprazan-based Dual and Triple Therapy for Helicobacter pylori Eradication
by: Jin Hee Noh, et al.
Published: (2023)

Role of Helicobacter pylori Eradication Therapy in Patients with Functional Dyspepsia
by: Sung Eun Kim
Published: (2023)

The Clinical Features and Helicobacter pylori Eradication Therapy in Lymphofollicular Gastritis: A Single Center Experience
by: Hong Ju An, et al.
Published: (2016)

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
by: Mohammadreza Seyyedmajidi, et al.
Published: (2019)

Can Helicobacter pylori Eradication Prevent the Development of Gastric Cancer?
by: Chang Seok Bang, et al.
Published: (2016)

Helicobacter pylori Eradication and Gastric Cancer Prevention
by: Chan Hyuk Park
Published: (2021)

Chemoprevention of Gastric Cancer: Helicobacter pylori Eradication
by: Eun Jin Kim, et al.
Published: (2017)

Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021)

First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study
by: Moon Won Lee, et al.
Published: (2018)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
by: Zinan Zhang, et al.
Published: (2023)

Evidence-based Therapy: A Rational Approach to Helicobacter pylori Eradication
by: Yong Hwan Kwon
Published: (2023)

Effect of Ecabet Sodium as an Adjuvant Therapy for Helicobacter pylori Eradication with Sequential Therapy
by: Hyun Lim
Published: (2018)

Russell Body Gastritis Disappeared after Helicobacter pylori Eradication
by: Key Jo Lee, et al.
Published: (2017)

Antibiotic resistances and eradication rates in Helicobacter pylori infection
by: Gonzalo Botija, et al.
Published: (2021)

Screening and Eradication of Helicobacter pylori for Gastric Cancer Prevention
by: Hyunchul Lim
Published: (2021)

Helicobacter pylori Eradication Restores the Diversity of Gastric Microbiota
by: Yong Sung Kim
Published: (2017)

Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
by: Qin Ma, et al.
Published: (2022)

Impact of eradication therapy of Helicobacter pylori in children with chronic immune thrombocytopenic purpura
by: Mahmoud M. Hodeib, et al.
Published: (2021)

Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection
by: Soo Yeon Choi, et al.
Published: (2023)